THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 121 filers reported holding THERAVANCE INC in Q3 2015. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $130,905,000 | +45.7% | 12,419,845 | -0.7% | 1.08% | +41.8% |
| Q3 2015 | $89,824,000 | -59.3% | 12,510,283 | +2.3% | 0.76% | -56.4% |
| Q2 2015 | $220,948,000 | +30.0% | 12,227,348 | +13.1% | 1.74% | +21.6% |
| Q1 2015 | $170,013,000 | +30.4% | 10,815,055 | +17.3% | 1.43% | +18.1% |
| Q4 2014 | $130,410,000 | -7.0% | 9,216,222 | +12.3% | 1.21% | -16.1% |
| Q3 2014 | $140,281,000 | -36.9% | 8,208,372 | +10.0% | 1.45% | -36.5% |
| Q2 2014 | $222,151,000 | +3.2% | 7,459,743 | +7.3% | 2.28% | -7.4% |
| Q1 2014 | $215,190,000 | -19.3% | 6,955,078 | -7.0% | 2.46% | -22.1% |
| Q4 2013 | $266,537,000 | +4.2% | 7,476,503 | +19.4% | 3.16% | -7.6% |
| Q3 2013 | $255,889,000 | -58.5% | 6,261,045 | +4.1% | 3.42% | -56.1% |
| Q2 2013 | $616,646,000 | – | 6,014,316 | – | 7.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 19,815,983 | $338,655,000 | 5.90% |
| Litespeed Management, L.L.C. | 2,670,695 | $45,642,000 | 1.76% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,790,913 | $47,697,000 | 1.76% |
| Proxima Capital Management, LLC | 915,000 | $15,637,000 | 1.69% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,196,372 | $140,076,000 | 1.44% |
| PERRY CAPITAL | 1,831,099 | $31,293,000 | 1.14% |
| Roundview Capital LLC | 140,145 | $2,395,000 | 1.08% |
| SECTORAL ASSET MANAGEMENT INC | 971,438 | $16,602,000 | 0.70% |
| Realm Partners LLC | 139,982 | $2,392,000 | 0.68% |
| BB BIOTECH AG | 743,244 | $12,702,000 | 0.52% |